Hints and tips:
...Poland’s health minister Adam Niedzielski said the deal favoured pharmaceutical companies, not EU citizens. He also demanded the confidential contract be published....
...Adam Barker, head of healthcare equity research at Goodbody, said the deal was “interesting” and that it showed that AstraZeneca’s focus was on several types of diseases....
US president speaks to Israel’s PM as Palestinians say the death toll in Gaza exceeds 10,000
...She has publicised an array of meetings with global leaders, often with her mother, including WHO director-general Tedros Adhanom Ghebreyesus and New York City mayor Eric Adams ahead of the UNGA, and with...
...Mr Adams declined to comment further, saying the investigation was continuing. US federal law required government funding to be disclosed in these circumstances, he noted....
...On Bramanteby Pier Paolo Tamburelli, MIT Press £32/$39.95 An unusual book, this, which uses the work of Donato Bramante to subtly explore some of the big issues in architecture — whether it can be considered...
...“Although [mRNA vaccines] have always shown promise, the infrastructure and experience with large scale manufacturing wasn’t there,” says Adam Barker, an analyst at Shore Capital....
...Adam Finn, professor of paediatrics at the University of Bristol and trial chief investigator, said it would be hard to assess the Cov-Boost results when published because we do not know “how boosting influences...
...Adam Barker, an analyst at Shore Capital, said GSK was focused on “smart allocation of resources”....
...Adam Barker, an analyst at Shore Capital, said the two metrics missed consensus estimates by 1 and 4 per cent, respectively....
...Adam Barker, an analyst at Shore Capital, cautioned that a resurgence in Covid-19 infections that is gathering pace could dent vaccination rates this winter and drive shares in GSK lower....
...It’s the most accessible of all the vaccines and so will still be used widely if approved,” said Shore Capital’s Adam Barker....
...Adam Barker, an analyst at Shore Capital, said sales at the vaccines business had missed analysts’ expectations by about 10 per cent....
...Adam Barker, an analyst at Shore Capital, said the move was a recognition of the potential of mRNA vaccine technology, which has gained more prominence in the pandemic....
...Adam Barker, an analyst at Shore Capital, said total revenue and core EPS for the quarter both beat consensus estimates. AstraZeneca’s London-listed shares added 2.6 per cent on Thursday....
...Adam Barker, analyst at Shore Capital, said the deal was a sign of Astra’s commitment to innovative cancer therapeutics....
...Adam Barker, an analyst at Shore Capital, said the development of an adjuvant would allow for a greater amount of the eventual vaccine to be “produced in a quicker time period”....
...Adam Barker, an analyst at Shore Capital, said: “With any vaccine, you’re only as strong as your weakest link and so pushing the development of a promising vaccine to protect people globally, also protects...
...Additional reporting by Donato Paolo Mancini...
...The company said on Thursday it was forming the “Mazars North America Alliance”, with US firms B KD, Dixon Hughes Goodman, Moss Adams, Plante Moran and Canada’s MNP....
...Now the deal is slightly complicated so we strongly suggest that you read the full article by Miles Johnson and Donato Paolo Mancini....
...California-born Jessica Rivera epitomises the younger, post-Upshaw generation of American soprano, as much at home in Golijov, Salonen and Adams as she is in the conventional song literature and uncommonly...
...interrupts Donato, the tailor who has been studiously taking my measurements. A zip please, I reply. “The right decision,” agrees Adam. I, and my crotch, are in safe hands....
International Edition